Literature DB >> 15791284

Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma.

Noriyoshi Fukushima1, Jens Koopmann, Norihiro Sato, Nijaguna Prasad, Ralph Carvalho, Steven D Leach, Ralph H Hruban, Michael Goggins.   

Abstract

The non-neoplastic pancreatic parenchyma adjacent to infiltrating ductal adenocarcinoma demonstrates inflammation, fibrosis, acinar cell loss and small duct-like metaplasia of acinar cells. Similar morphologic changes are also observed in the setting of chronic pancreatitis. In addition, peritumoral acini have been shown to have alterations in gene expression even in the absence of morphological changes. To better understand the pancreatic acinar responses to infiltrating pancreatic ductal adenocarcinoma, we characterized gene expression patterns of pancreatic acinar tissue adjacent to infiltrating pancreatic ductal adenocarcinomas and compared them to gene expression patterns of acinar tissue affected by chronic pancreatitis as well as to those of normal pancreatic acini. Fresh-frozen pancreatic acinar tissue was microdissected from nine patients (three with pancreatic cancer, three with chronic pancreatitis, three with normal pancreata) using laser capture microdissection, and extracted RNA from each microdissection was subjected to two rounds of linear amplification and hybridized to oligonucleotide microarrays. Gene expression patterns were confirmed using quantitative RT-PCR and/or immunohistochemistry. A total of 20 genes was found to be overexpressed in peritumoral acinar tissue compared to normal acinar tissue and to acini affected by chronic pancreatitis. These 20 genes included pancreatitis-associated protein (HIP/PAP), a gene known to be overexpressed in acini adjacent to infiltrating pancreatic cancer, and the gene cartilage glycoprotein-39 (HC gp-39 or TKL-40). Serum HC gp-39 protein levels were significantly higher in patients with pancreatic cancer and in those with chronic pancreatitis than in controls without pancreatic disease. There was no significant difference in the levels of serum HC gp-39 in patients with pancreatic cancer and those with chronic pancreatitis. Our results demonstrate some of the molecular alterations in acinar cells that occur in response to adjacent infiltrating pancreatic ductal adenocarcinoma and reveal that such alterations can provide a rich source of markers of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15791284     DOI: 10.1038/modpathol.3800337

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  28 in total

Review 1.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

Review 2.  SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.

Authors:  Ferda Kaleağasıoğlu; Martin R Berger
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk.

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

4.  SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer.

Authors:  Jun Wang; Hong Zhou; Yong Han; Xiulan Liu; Min Wang; Xin Wang; Guoxiao Yin; Xu Li; Ming Xiang
Journal:  J Mol Med (Berl)       Date:  2014-07-05       Impact factor: 4.599

5.  Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines.

Authors:  Yongzhong Wu; Jiamo Lu; Smitha Antony; Agnes Juhasz; Han Liu; Guojian Jiang; Jennifer L Meitzler; Melinda Hollingshead; Diana C Haines; Donna Butcher; Krishnendu Roy; James H Doroshow
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

6.  Synthesis and ex vivo autoradiographic evaluation of ethyl-β-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-β-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PET.

Authors:  Yunming Ying; Pradip Ghosh; Liwei Guo; Ashutosh Pal; Uday Mukhapadhyay; Zhenghong Peng; Hsin Hsien Yeh; Susanna Bertolini; Leo Garcia Flores; Daniel Young; Andrei Volgin; Suren Soghomonyan; William Bornmann; Craig Logsdon; Mian M Alauddin; Juri G Gelovani
Journal:  Mol Imaging Biol       Date:  2011-06       Impact factor: 3.488

7.  Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts.

Authors:  Thiruvengadam Arumugam; Vincenzo Paolillo; Daniel Young; XiaoXia Wen; Craig D Logsdon; Louis De Palatis; Mian M Alauddin
Journal:  Nucl Med Biol       Date:  2014-08-08       Impact factor: 2.408

8.  An improved synthesis of 1'-[18F]fluoroethyl-β-D-lactose ([18F]-FEL) for positron emission tomography imaging of pancreatic cancer.

Authors:  Nashaat Turkman; Juri G Gelovani; Mian M Alauddin
Journal:  J Labelled Comp Radiopharm       Date:  2013-03-22       Impact factor: 1.921

9.  IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.

Authors:  Yongzhong Wu; Mariam M Konaté; Jiamo Lu; Hala Makhlouf; Rodrigo Chuaqui; Smitha Antony; Jennifer L Meitzler; Michael J Difilippantonio; Han Liu; Agnes Juhasz; Guojian Jiang; Iris Dahan; Krishnendu Roy; James H Doroshow
Journal:  J Immunol       Date:  2019-09-23       Impact factor: 5.422

10.  Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT.

Authors:  Leo Garcia Flores; Susanna Bertolini; Hsin Hsin Yeh; Daniel Young; Uday Mukhopadhyay; Ashutosh Pal; Yunming Ying; Andrei Volgin; Aleksandr Shavrin; Suren Soghomonyan; William Tong; William Bornmann; Mian M Alauddin; Craig Logsdon; Juri G Gelovani
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.